High baseline prevalence of atopic comorbidities and medication use in children treated with allergy immunotherapy in the REAl-world effeCtiveness in allergy immunoTherapy (REACT) study
BackgroundRespiratory allergy, commonly manifesting as allergic rhinitis (AR) and asthma, is a chronic progressive disease that frequently starts in childhood. Allergy immunotherapy (AIT) is the only causal treatment for respiratory allergy with the potential to modify the underlying cause of allerg...
Saved in:
Main Authors: | Benedikt Fritszching (Author), Celeste Porsbjerg (Author), Sarah Buchs (Author), Julie Rask Larsen (Author), Nick Freemantle (Author), Marco Contoli (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma: Results from the REACT study, a retrospective cohort study.
by: Benedikt Fritzsching, et al.
Published: (2022) -
Need for longitudinal studies to assess the real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma - Authors´ reply
by: Benedikt Fritzsching, et al.
Published: (2022) -
Immunotherapy for pet allergies
by: Tuomas Virtanen
Published: (2018) -
Immunotherapy for cow's milk allergy
by: Shoichiro Taniuchi, et al.
Published: (2017) -
Immunotherapy of house dust mite allergy
by: Lin Yang, et al.
Published: (2017)